05/16/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:30 PM | EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:30 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:10 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
3:30 PM | SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:30 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/03/2024
3:04 PM | SULLIVAN LOUIS W (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
5:32 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2024
5:34 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
6:00 AM | United Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
6:02 AM | United Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
6:07 AM | United Therapeutics (Filer)
| Form ARS | |
04/25/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:30 PM | DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:07 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:56 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
5:03 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:33 PM | Olian Judy D. (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Klein Katherine J (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (Ad) Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks." And these will be the biggest winners |
03/07/2024
3:52 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:30 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:33 PM | Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:50 PM | ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:03 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
3:31 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
5:03 AM | United Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2024
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:36 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:57 PM | ROTHBLATT MARTINE A (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
8:05 AM | Avoro Capital Advisors LLC (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
8:50 AM | RENAISSANCE TECHNOLOGIES LLC (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
9:18 AM | United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/08/2024
5:00 AM | Celularity Inc (Subject)
Celularity Inc (Subject)
United Therapeutics (Filed by)
| Form SC 13G/A | |
02/02/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:29 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
United Therapeutics (Subject)
| Form SC 13G/A | |
01/18/2024
4:56 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:12 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:06 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
8:51 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC 13D | |
12/21/2023
3:56 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:00 PM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:53 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:30 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
4:40 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
1:06 PM | Miromatrix Medical Inc. (Issuer)
United Therapeutics (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2023
4:29 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
9:03 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T/A | |
12/12/2023
3:37 PM | CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
9:52 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T/A | |
12/07/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
3:30 PM | Giltner Richard (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:30 PM | Olian Judy D. (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
5:00 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:01 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
5:06 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-T | |
11/08/2023
3:30 PM | PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
4:24 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:50 PM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
11/01/2023
5:03 AM | United Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
5:05 AM | United Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
6:06 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad) Are you monitoring 13,217 cryptocurrencies everyday?
If not, you could miss the ONE that can make you wealthy beyond your wildest dreams.
You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. |
10/30/2023
6:09 AM | Miromatrix Medical Inc. (Subject)
United Therapeutics (Filed by)
| Form SC TO-C | |
10/20/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/19/2023
4:54 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
3:23 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:30 PM | MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
3:23 PM | MAHON PAUL A (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2023
3:30 PM | Mesa Nilda (Reporting)
United Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
4:12 PM | Mesa Nilda (Reporting)
United Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
